Table 1.
Summary of hospital metrics and daily defined doses
| Summaries | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | Grand total |
|---|---|---|---|---|---|---|---|
| Hospital metrics | |||||||
| Total patient visits (%) | 155 560 (15.1) | 161 084 (15.7) | 177 969 (17.3) | 192 428 (18.7) | 163 336 (15.9) | 177 639 (17.3) | 1 028 016 (100) |
| Hospital admissions (%) | 16 350 (16.7) | 16 348 (16.7) | 16 340 (16.7) | 16 326 (16.7) | 16 324 (16.7) | 16 332 (16.7) | 98 020 (100) |
| Number of ATC level 4 antibiotics prescribed | 14 | 14 | 14 | 14 | 15 | 15 | 15 |
| Number of ATC level 5 antibiotics prescribed | 24 | 25 | 24 | 26 | 24 | 25 | 26 |
| Distinct Access antibiotics prescribed | 11 | 11 | 13 | 12 | 10 | 11 | 13 |
| Distinct Watch antibiotics prescribed | 8 | 9 | 10 | 8 | 8 | 9 | 10 |
| Distinct Reserve antibiotics prescribed | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Distinct unclassified antimicrobials prescribed | 0 | 0 | 0 | 1 | 0 | 1 | 1 |
| Volume in DDD (%) of antibiotics issued per year | |||||||
| All antibiotics | 397 276.6 | 497 341.3 | 514 471.3 | 422 362.0 | 361 231.0 | 437 103.4 | 2 629 786.0 |
| Access antimicrobial | 280 071.0 (70.5) | 337 892.9 (67.9) | 325 579.4 (62.4) | 251 884.9 (59.6) | 222 921.8 (61.7) | 239 780.1 (54.9) | 1 658 130.0 (63.3) |
| Watch antimicrobials | 117 205.6 (29.5) | 159 448.4 (32.1) | 188 891.9 (36.7) | 170 469.6 (40.4) | 138 309.2 (38.3) | 197 283.2 (45.1) | 971 608.0 (36.7) |
| Reserve antimicrobials | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Unclassified antimicrobials | 0 | 0 | 0 | 7.5 (0.002) | 0 | 40.0 (0.01) | 47.5 (0.002) |
| Oral antimicrobials | 350 764.1 (88.3) | 454 502.5 (91.4) | 464 406.0 (90.3) | 360 646.8 (85.4) | 298 642.7 (82.7) | 375 286.9 (85.9) | 2 304 249.0 (87.7) |
| Parenteral antimicrobials | 46 512.5 (11.7) | 42 838.8 (8.6) | 50 065.3 (9.7) | 61 715.2 (14.6) | 62 588.3 (17.3) | 61 816.4 (14.1) | 325 536.4 (12.3) |
| Generic antimicrobials | 396 545.1 (99.8) | 496 467.0 (99.8) | 508 526.8 (98.8) | 413 674.9 (97.9) | 355 647.8 (98.5) | 427 825.3 (97.9) | 2 598 687 (98.9) |
| Originator antimicrobials | 731.5 (0.2) | 874.3 (0.2) | 5944.5 (1.2) | 8687.1 (2.1) | 5583.2 (1.5) | 9278.0 (2.1) | 31 098.6 (1.1) |
| Paediatric formulation | 25 797.5 | 26 633.8 | 28 363.3 | 24 635.2 | 13 427.3 | 25 552.2 | 144 409.4 (5.5) |
| Adult formulation | 371 479.1 | 470 707.5 | 486 108.0 | 397 726.7 | 347 803.7 | 411 551.2 | 2 485 376.0 (94.5) |
| Access-to-Watch ratio | 2.4 | 2.1 | 1.7 | 1.5 | 1.6 | 1.2 | |
*%. Percentages: unclassified antimicrobials include Ceftriaxone sulbactam and Ciprofloxacin tinidazole.